Part two of seven: Dr. Shahida Din, Chair of our IBD Committee, and Dr. Jonathan Blackwell—both Consultant Gastroenterologists at the Edinburgh IBD Unit—are joined by Mrs. Fiona Rees, Consultant Pharmacist at University Hospitals Sussex, to explore the BSG IBD Guidelines with a focus on therapy de-escalation. Together, they discuss how best to manage patient expectations around treatment and outcomes.
They also take a detailed look at the role of Mesalazine, routes of administration, Thiopurines, anti-TNF therapies, Pulse Therapy, and the importance of continually reassessing treatment plans.
In this episode, Dr. Asma Fikree, Consultant Neurogastroenterologist at UCLH and Chair of the BSG Neurogastroenterology & Motility Section and Dr Maria Eugenicos, Senior...
Dr. Jabed Ahmed and Dr. Ravi Ranjan discuss colorectal polyps in patients with limited life expectancy. The bowel cancer screening strategies rely on the...
Professor Vikram Mitra (Chair, Pancreas Clinical Section, British Society of Gastroenterology) speaks with Professor Pramod Garg, President of the Indian Society of Gastroenterology, about...
